✦ LIBER ✦

A phase I trial of dose-dense (biweekly) carboplatin combined with paclitaxel and pegfilgrastim: A feasibility study in patients with untreated Stage III and IV ovarian, tubal or primary peritoneal cancer: A Gynecologic Oncology Group study

✍ Scribed by Amy D. Tiersten; Michael W. Sill; Danielle Knight; Franco Muggia; Agustin A. Garcia; Ron Swensen; David P. Warshal; Robert S. Mannel; Paula M. Fracasso

Book ID: 113962506
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 226 KB
Volume: 118
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2010.05.020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I feasibility trial of carboplatin

Phase I feasibility trial of carboplatin, paclitaxel, and gemcitabine in patients with previously untreated epithelial ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study

✍ Katherine Y Look; Michael A Bookman; Jessie Schol; Thomas J Herzog; Thomas Rocer 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 128 KB

A phase I study with an expanded cohort

A phase I study with an expanded cohort to assess the feasibility of intravenous paclitaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with untreated ovarian, fallopian tube or primary peritoneal carcinoma: A Gynecologic Oncology Group study

✍ Natalie Gould; Michael W. Sill; Robert S. Mannel; P.H. Thaker; Paul DiSilvestro; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 162 KB

A phase I study with an expanded cohort

A phase I study with an expanded cohort to assess feasibility of intravenous docetaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with previously untreated ovarian, fallopian tube or primary peritoneal carcinoma: A Gynecologic Oncology Group study

✍ Natalie Gould; Michael W. Sill; Robert S. Mannel; Premal H. Thaker; Paul A. DiSi 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 162 KB

A phase I study with an expanded cohort

A phase I study with an expanded cohort to assess the feasibility of intraperitoneal carboplatin and intravenous paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A Gynecologic Oncology Group study

✍ Mark A. Morgan; Michael W. Sill; Keiichi Fujiwara; Benjamin Greer; Stephen C. Ru 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 172 KB

A randomized phase III trial of IV carbo

A randomized phase III trial of IV carboplatin and paclitaxel × 3 courses followed by observation versus weekly maintenance low-dose paclitaxel in patients with early-stage ovarian carcinoma: A Gynecologic Oncology Group Study

✍ Robert S. Mannel; Mark F. Brady; Elise C. Kohn; Parviz Hanjani; Masamichi Hiura; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 371 KB

Randomized phase III trial of chemoimmun

Randomized phase III trial of chemoimmunotherapy in patients with previously untreated stages III and IV suboptimal disease ovarian cancer: A Southwest Oncology Group study

✍ David S. Alberts; Nancy Mason-Liddil; Robert V. O'Toole; Thomas M. Abbott; Richa 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 763 KB